Blog
Vera Bradley Q1 Earnings Call Highlights
Key Points
- Interested in Vera Bradley, Inc.? Here are five stocks we like better.
- Vera Bradley returned to year-over-year revenue growth in fiscal Q1, with sales up 7.8% to $55.7 million and
Anterix Q4 Earnings Call Highlights
Key Points
- Interested in Anterix Inc.? Here are five stocks we like better.
- Utility demand accelerated in late fiscal 2026, with management saying customer conversations are shifting from
3 Stocks Cashing In on AI While Everyone Watches NVIDIA
Key Points
- Interested in Quanta Services, Inc.? Here are five stocks we like better.
- Marc Chaikin of Chaikin Analytics argues that AI infrastructure stocks, not semiconductors, represent the next
2 Ways to Play the QXO/TopBuild Deal
Key Points
- Interested in QXO, Inc.? Here are five stocks we like better.
- QXO continues its acquisition spree with a $17-billion deal to buy rival TopBuild, announced in April 2026.
- The building
Capricor Therapeutics Eyes FDA Approval Path for Duchenne Cell Therapy
Key Points
- Interested in Capricor Therapeutics, Inc.? Here are five stocks we like better.
- Capricor Therapeutics says it is in active discussions with the FDA to support approval of deramiocel
Aurora Cannabis Q4 Earnings Call Highlights
Key Points
- Interested in Aurora Cannabis Inc.? Here are five stocks we like better.
- Aurora Cannabis beat fiscal 2026 expectations, with net revenue of CAD 321 million, adjusted EBITDA up 32%
Major Drilling Group International Q4 Earnings Call Highlights
Key Points
- Interested in Major Drilling Group International Inc.? Here are five stocks we like better.
- Record fiscal 2026 performance: Major Drilling reported annual revenue of CAD 889
Wolfspeed Ditches EV Woes for High-Margin Defense Jets
Key Points
- Interested in Wolfspeed, Inc.? Here are five stocks we like better.
- Wolfspeed signed a June 8 MOU with GE Aerospace to develop silicon carbide power modules for aerospace, defense, and
Casey’s Is Looking Like a Hot Buy as Growth, Buybacks, and Guidance Align
Key Points
- Interested in Casey's General Stores, Inc.? Here are five stocks we like better.
- Casey's General Stores uptrend is intact and on track for fresh highs this year.
- Analysts and
The “Duck Stock” Keeps Quietly Making Money for Shareholders
Key Points
- Interested in Aflac Incorporated? Here are five stocks we like better.
- Aflac generates steady cash flow through supplemental insurance and long-standing market positions in the U.S
As Shares Fall, Analyst Are Boosting their Broadcom Price Targets
Key Points
- Interested in Broadcom Inc.? Here are five stocks we like better.
- Broadcom took a hit after its most recent earnings report, giving up big time gains achieved before the report.
GCP Infrastructure Investments H1 Earnings Call Highlights
Key Points
- Interested in GCP Infrastructure Investments Limited? Here are five stocks we like better.
- GCP Infrastructure Investments reported £829 million NAV and said the portfolio remained in
Sequoia Economic Infrastructure H2 Earnings Call Highlights
Key Points
- Interested in Sequoia Economic Infrastructure Inc? Here are five stocks we like better.
- Sequoia Economic Infrastructure reported a resilient fiscal 2026, keeping its dividend
BrightSpring Health Services Sees Specialty Pharmacy, Tuck-In Deals Fueling Growth
Key Points
- Interested in BrightSpring Health Services, Inc.? Here are five stocks we like better.
- BrightSpring’s growth is being driven by specialty pharmacy, especially limited distribution
PayPoint H2 Earnings Call Highlights
Key Points
- Interested in PayPoint plc? Here are five stocks we like better.
- PayPoint posted record annual results, with underlying pre-tax profit up to GBP 69 million, underlying EBITDA at GBP
Wizz Air Q4 Earnings Call Highlights
Key Points
- Interested in Wizz Air Holdings Plc? Here are five stocks we like better.
- Wizz Air returned to pre-tax profitability, reporting €27 million in pre-tax profit and nearly €1 billion
NCC Group H1 Earnings Call Highlights
Key Points
- Interested in NCC Group plc? Here are five stocks we like better.
- NCC Group completed a major strategic reset by selling Escode and is now positioned as a pure-play cybersecurity
Halma H2 Earnings Call Highlights
Key Points
- Interested in Halma plc? Here are five stocks we like better.
- Halma delivered a very strong FY2026, with 16.2% organic revenue growth, 20.3% adjusted EBIT growth, and a
Apogee Therapeutics Maps Phase 3 Push for Zumilokibart, Backed by Blackstone Funding
Key Points
- Interested in Apogee Therapeutics Inc.? Here are five stocks we like better.
- Apogee Therapeutics plans to start Phase 3 trials of zumilokibart in moderate-to-severe atopic
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
Key Points
- Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amphastar is shifting its strategy from complex generics toward proprietary drugs and
Navan Q1 Earnings Call Highlights
Key Points
- Interested in Navan, Inc.? Here are five stocks we like better.
- Navan delivered strong Q1 results, with gross bookings up 50% year over year to $3.1 billion and revenue up 40% to
Oxford Industries Q1 Earnings Call Highlights
Key Points
- Interested in Oxford Industries, Inc.? Here are five stocks we like better.
- Oxford Industries said first-quarter sales were roughly in line with expectations, while adjusted
Oracle Q4 Earnings Call Highlights
Key Points
- Interested in Oracle Corporation? Here are five stocks we like better.
- Oracle posted a record fiscal Q4 with revenue of $19.2 billion, up 21%, while full-year revenue topped $67
Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape
Key Points
- Interested in Amylyx Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amylyx expects Phase 3 topline results for avexitide in Q3 as it advances the drug for
Stitch Fix Q3 Earnings Call Highlights
Key Points
- Interested in Stitch Fix, Inc.? Here are five stocks we like better.
- Stitch Fix beat third-quarter expectations with revenue up 4.7% year over year to $340.3 million and adjusted